Human CYP2B6 in alcohol metabolism and alcoholic liver injury
Human CYP2B6 in alcohol metabolism and alcoholic liver injury
批准号:
10037957
负责人:
Hongbing Wang
金额:
$22.21万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-10 至 2022-08-31
关键词:
AcetaldehydeAcuteAffectAgonistAlcohol consumptionAlcohol dehydrogenaseAlcoholic Liver DiseasesAlcoholic steatohepatitisAlcoholsArizonaBiological AssayBloodCYP1A2 geneCYP2B6 geneCYP2E1 geneCYP3A4 geneCause of DeathCell Culture TechniquesCessation of lifeChronicCirrhosisClinicalCytochrome P450DataDrug Metabolic DetoxicationDrug usageEnzymesEthanolEthanol MetabolismExcretory functionExperimental ModelsFatty LiverFibrosisFutureGenesHeavy DrinkingHepG2HepaticHepatocyteHumanIn VitroIngestionInjectionsIntakeInvestigationKineticsKnockout MiceKnowledgeLettersLiverLiver diseasesMediatingMetabolicMetabolic PathwayMetabolismMicrosomesMitochondriaMonoclonal AntibodiesMorbidity - disease rateMusOutcomeOximesPathologicPatientsPharmaceutical PreparationsPlayPrevalencePrimary carcinoma of the liver cellsProdrugsPropaneResearchRoleSystemTailTestingThiazolesTranscriptional RegulationUnited StatesUniversitiesUp-RegulationVeinsWild Type MouseXenobioticsacetaldehyde dehydrogenasealcohol misusealcohol use disorderanalogbasebinge drinkerbinge drinkingchronic alcohol ingestionchronic liver diseaseconstitutive androstane receptorcytotoxicitydefined contributionepidemiology studyfeedinghigh riskhumanized mouseimprovedin vivoinhibitor/antagonistliver injuryloss of functionmortalitymouse modelnoveloverexpressionoxidationreceptor expressionresponsestable cell linetranscription factoryoung adult
中文摘要
项目摘要:
过度饮酒是造成全球发病率和死亡率负担的主要因素,
酒精性肝病(ALD)的原因,占全球酒精相关死亡的25%。
ALD的范围从相对轻度的肝脂肪变性、酒精性脂肪性肝炎和纤维化,
不可逆肝硬化和肝细胞癌。流行病学研究表明,酗酒,高-
风险酒精消费方式,已成为越来越受欢迎的年轻人;和频繁的狂欢
饮酒者患严重酒精性肝病的风险更高。然而,酗酒的潜在机制-
诱导的肝损伤和是否有一个适应性的酶系统,代谢高浓度的
酗酒后的酒精是知之甚少。我们的初步数据表明,慢性乙醇
喂食加暴饮暴食显著诱导细胞色素P450 2b 10的肝脏表达
(Cyp2b10)。在酒精狂饮后,Cyp 2b 10基因敲除小鼠的血液乙醇水平显著升高,
高于野生型小鼠。此外,长期加酗酒酒精喂养导致更大的肝脏
Cyp 2b 10基因敲除小鼠中的损伤比野生型小鼠中的损伤小。这些令人兴奋的发现导致了
假设人CYP 2B 6,鼠CYP 2B 10的类似物,在狂饮中起重要作用-
诱导ALD,而CYP 2B 6酶的适应性诱导协调了一种新的保护机制
潜在的ALD。我们将在两个提出的具体目标中检验这一假设:目标1是确定CYP 2B 6-
目的2将研究CYP 2B 6在乙醇中的作用
在人源化小鼠模型中的暴食诱导的肝损伤。这些研究将为以下方面提供必要的基础:
确定并验证CYP 2B 6/Cyp 2b 10介导的适应性代谢的新代谢途径
以及在暴饮暴食后对过量酒精的解毒。
英文摘要
Project Summary:
Excessive consumption of alcohol is a major contributor to the global burden of morbidity and mortality, and is
the cause of alcoholic liver disease (ALD) that accounts for up to 25% of alcohol-associated deaths worldwide.
The spectrum of ALD ranges from relatively mild hepatic steatosis, alcoholic steatohepatitis and fibrosis, to
irreversible cirrhosis and hepatocellular carcinoma. Epidemiological studies reveal that binge drinking, a high-
risk alcohol consumption style, has become increasingly popular among young adults; and frequent binge
drinkers are at higher risk for developing severe ALD. However, the mechanisms underlying alcohol binge-
induced liver injury and whether there is an adaptive enzymatic system that metabolizes high concentrations of
ethanol after binge drinking are poorly understood. Our preliminary data demonstrate that chronic ethanol
feeding plus binge administration drastically induces hepatic expression of the cytochrome P450 2b10
(Cyp2b10) in mice. After alcohol binge ingestion blood ethanol levels of Cyp2b10-null mice were significantly
higher than that of wild-type mice. Moreover, chronic-plus-binge ethanol feeding resulted in greater liver
damage in Cyp2b10-null mice than that in wild-type mice. These exciting findings have led to the overarching
hypothesis that human CYP2B6, the analog of murine Cyp2b10, plays an important role in binge drinking-
induced ALD, and that adaptive induction of CYP2B6 enzyme coordinates a novel protective mechanism
underlying ALD. We will test this hypothesis in two proposed specific aims: Aim 1 is to determine CYP2B6-
mediated metabolism of ethanol in human liver cells; and Aim 2 will investigate the role of CYP2B6 in ethanol
binge-induced liver injury in humanized mouse model. These studies will provide necessary groundwork for
identifying and validating a novel metabolic pathway-mediated by CYP2B6/Cyp2b10 for adaptive metabolism
and detoxification of excessive alcohol after binge ingestion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel noncanonical actions of CAR in human Liver
-
批准号:10445324
-
项目类别:
-
资助金额:$39.08万
-
财政年份:2021
-
负责人:Hongbing Wang
-
依托单位:
Novel noncanonical actions of CAR in human Liver
-
批准号:10275448
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2021
-
负责人:Hongbing Wang
-
依托单位:
Novel noncanonical actions of CAR in human Liver
-
批准号:10650357
-
项目类别:
-
资助金额:$39.26万
-
财政年份:2021
-
负责人:Hongbing Wang
-
依托单位:
Mechanism underlying cognitive and synaptic flexibility
-
批准号:10305632
-
项目类别:
-
资助金额:$48.79万
-
财政年份:2020
-
负责人:Hongbing Wang
-
依托单位:
Mechanism underlying cognitive and synaptic flexibility
-
批准号:10515330
-
项目类别:
-
资助金额:$46.22万
-
财政年份:2020
-
负责人:Hongbing Wang
-
依托单位:
Human CYP2B6 in alcohol metabolism and alcoholic liver injury
-
批准号:10256633
-
项目类别:
-
资助金额:$18.35万
-
财政年份:2020
-
负责人:Hongbing Wang
-
依托单位:
Nonconventional role of ADCY in Gq-mediated neuronal signaling and neuroplasticity
-
批准号:10082304
-
项目类别:
-
资助金额:$44.65万
-
财政年份:2019
-
负责人:Hongbing Wang
-
依托单位:
Nonconventional role of ADCY in Gq-mediated neuronal signaling and neuroplasticity
-
批准号:10577826
-
项目类别:
-
资助金额:$44.92万
-
财政年份:2019
-
负责人:Hongbing Wang
-
依托单位:
Nonconventional role of ADCY in Gq-mediated neuronal signaling and neuroplasticity
-
批准号:10338100
-
项目类别:
-
资助金额:$44.81万
-
财政年份:2019
-
负责人:Hongbing Wang
-
依托单位:
Nonconventional role of ADCY in Gq-mediated neuronal signaling and neuroplasticity
-
批准号:9900871
-
项目类别:
-
资助金额:$44.74万
-
财政年份:2019
-
负责人:Hongbing Wang
-
依托单位:
Function and Regulation of SLC13A5 in the Liver
-
批准号:10082455
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2018
-
负责人:Hongbing Wang
-
依托单位:
Role of constitutive androstane receptor in cyclophosphamide-based chemotherapy
-
批准号:8556721
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2013
-
负责人:Hongbing Wang
-
依托单位:
Role of constitutive androstane receptor in cyclophosphamide-based chemotherapy
-
批准号:9066528
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2013
-
负责人:Hongbing Wang
-
依托单位:
Role of constitutive androstane receptor in cyclophosphamide-based chemotherapy
-
批准号:8725710
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2013
-
负责人:Hongbing Wang
-
依托单位:
Connecting mGluR and cAMP in the pre-clinical model of Fragile X
-
批准号:8769169
-
项目类别:
-
资助金额:$37.77万
-
财政年份:2012
-
负责人:Hongbing Wang
-
依托单位:
Connecting mGluR and cAMP in the pre-clinical model of Fragile X
-
批准号:8973575
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2012
-
负责人:Hongbing Wang
-
依托单位:
Connecting mGluR and cAMP in the pre-clinical model of Fragile X
-
批准号:8416959
-
项目类别:
-
资助金额:$36.3万
-
财政年份:2012
-
负责人:Hongbing Wang
-
依托单位:
Connecting mGluR and cAMP in the pre-clinical model of Fragile X
-
批准号:8586905
-
项目类别:
-
资助金额:$37.79万
-
财政年份:2012
-
负责人:Hongbing Wang
-
依托单位:
Connecting mGluR and cAMP in the pre-clinical model of Fragile X
-
批准号:8238439
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2012
-
负责人:Hongbing Wang
-
依托单位:
Function and Property of Extrasynaptic NMDAR in Neuronal Cell Death
-
批准号:8142759
-
项目类别:
-
资助金额:$6.89万
-
财政年份:2010
-
负责人:Hongbing Wang
-
依托单位:
海外基金